Per Patient Reimbursment (CTBM100C2412): A multi-center, human factors engineering (HFE) usability study in cystic fibrosis patients to validate the approved instructions for use(IFU) of TOBI® Podhaler? (tobramycin inhalation powder) using placebo capsu

Project: Research project

Project Details

StatusFinished
Effective start/end date11/1/1412/31/16

Funding

  • Novartis Pharmaceuticals Corporation